Excess Mortality in Europe Coincides with Peaks of COVID-19, Influenza and Respiratory Syncytial Virus (RSV), November 2023 to February 2024

Since the end of November 2023, the European Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023-6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI:  91.7-98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season.

Citing Articles

RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010-2022.

Haeberer M, Mengel M, Fan R, Toquero-Asensio M, Martin-Toribio A, Liu Q Infect Dis Ther. 2024; 13(9):1983-1999.

PMID: 39033476 PMC: 11343947. DOI: 10.1007/s40121-024-01021-1.

References

Lomholt F, Emborg H, Norgaard S, Nielsen J, Munkstrup C, Moller K . Resurgence of Respiratory Syncytial Virus in the Summer of 2021 in Denmark-a Large out-of-season Epidemic Affecting Older Children. Open Forum Infect Dis. 2024; 11(3):ofae069. PMC: 10941316. DOI: 10.1093/ofid/ofae069. View

Fouillet A, Pontais I, Caserio-Schonemann C . Excess all-cause mortality during the first wave of the COVID-19 epidemic in France, March to May 2020. Euro Surveill. 2020; 25(34). PMC: 7453680. DOI: 10.2807/1560-7917.ES.2020.25.34.2001485. View

Emborg H, Vestergaard L, Botnen A, Nielsen J, Krause T, Trebbien R . A late sharp increase in influenza detections and low interim vaccine effectiveness against the circulating A(H3N2) strain, Denmark, 2021/22 influenza season up to 25 March 2022. Euro Surveill. 2022; 27(15). PMC: 9012088. DOI: 10.2807/1560-7917.ES.2022.27.15.2200278. View

Munkstrup C, Lomholt F, Emborg H, Moller K, Krog J, Trebbien R . Early and intense epidemic of respiratory syncytial virus (RSV) in Denmark, August to December 2022. Euro Surveill. 2023; 28(1). PMC: 9817209. DOI: 10.2807/1560-7917.ES.2023.28.1.2200937. View

Vestergaard L, Molbak K . Timely monitoring of total mortality associated with COVID-19: informing public health and the public. Euro Surveill. 2020; 25(34). PMC: 7453681. DOI: 10.2807/1560-7917.ES.2020.25.34.2001591. View

Bermudez Barrezueta L, Matias Del Pozo V, Lopez-Casillas P, Brezmes Raposo M, Gutierrez Zamorano M, Pino Vazquez M . Variation in the seasonality of the respiratory syncytial virus during the COVID-19 pandemic. Infection. 2022; 50(4):1001-1005. PMC: 8938970. DOI: 10.1007/s15010-022-01794-y. View

Nielsen J, Mazick A, Andrews N, Detsis M, Fenech T, Flores V . Pooling European all-cause mortality: methodology and findings for the seasons 2008/2009 to 2010/2011. Epidemiol Infect. 2012; 141(9):1996-2010. PMC: 9151408. DOI: 10.1017/S0950268812002580. View

Mazick A, Gergonne B, Nielsen J, Wuillaume F, Virtanen M, Fouillet A . Excess mortality among the elderly in 12 European countries, February and March 2012. Euro Surveill. 2012; 17(14). View

Sinnathamby M, Whitaker H, Coughlan L, Lopez Bernal J, Ramsay M, Andrews N . All-cause excess mortality observed by age group and regions in the first wave of the COVID-19 pandemic in England. Euro Surveill. 2020; 25(28). PMC: 7376843. DOI: 10.2807/1560-7917.ES.2020.25.28.2001239. View

10.

Abu-Raya B, Vineta Paramo M, Reicherz F, Lavoie P . Why has the epidemiology of RSV changed during the COVID-19 pandemic?. EClinicalMedicine. 2023; 61:102089. PMC: 10359735. DOI: 10.1016/j.eclinm.2023.102089. View

11.

Adlhoch C, Mook P, Lamb F, Ferland L, Melidou A, Amato-Gauci A . Very little influenza in the WHO European Region during the 2020/21 season, weeks 40 2020 to 8 2021. Euro Surveill. 2021; 26(11). PMC: 7976381. DOI: 10.2807/1560-7917.ES.2021.26.11.2100221. View

12.

Emborg H, Carnahan A, Bragstad K, Trebbien R, Brytting M, Hungnes O . Abrupt termination of the 2019/20 influenza season following preventive measures against COVID-19 in Denmark, Norway and Sweden. Euro Surveill. 2021; 26(22). PMC: 8176675. DOI: 10.2807/1560-7917.ES.2021.26.22.2001160. View

13.

Vestergaard L, Nielsen J, Krause T, Espenhain L, Tersago K, Bustos Sierra N . Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017. Euro Surveill. 2017; 22(14). PMC: 5388126. DOI: 10.2807/1560-7917.ES.2017.22.14.30506. View

14.

Michelozzi P, deDonato F, Scortichini M, De Sario M, Noccioli F, Rossi P . Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system, Italy, 1 February to 18 April 2020. Euro Surveill. 2020; 25(19). PMC: 7238743. DOI: 10.2807/1560-7917.ES.2020.25.19.2000620. View

15.

Norgaard S, Vestergaard L, Nielsen J, Richter L, Schmid D, Bustos N . Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020. Euro Surveill. 2021; 26(2). PMC: 7809719. DOI: 10.2807/1560-7917.ES.2021.26.1.2002023. View

16.

Vestergaard L, Nielsen J, Richter L, Schmid D, Bustos N, Braeye T . Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020. Euro Surveill. 2020; 25(26). PMC: 7346364. DOI: 10.2807/1560-7917.ES.2020.25.26.2001214. View

17.

Nielsen J, Vestergaard L, Richter L, Schmid D, Bustos N, Asikainen T . European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of influenza B be reconsidered?. Clin Microbiol Infect. 2019; 25(10):1266-1276. DOI: 10.1016/j.cmi.2019.02.011. View